Asia Pacific Molecular Biology Enzymes, Kits, and Reagents Market Share and Forecast by 2028

The molecular biology enzymes, kits, and reagents market in APAC is expected to grow from US$ 2,445.67 million in 2021 to US$ 7,809.89 million by 2028; it is estimated to grow at a CAGR of 18.0% from 2021 to 2028.

Australia, China, India, Japan, and South Korea are major economies in APAC. Increasing demand of molecular diagnostics is the major factor driving the growth of the APAC molecular biology enzymes, kits, and reagents market. Increased adoption of molecular diagnostics procedures for detecting infectious diseases, coupled with advent of new cancer diagnostic solutions, is likely to support the molecular biology enzymes, kits, and reagents market growth during the forecast period. Molecular diagnostics tests are used for detecting disturbance between specific sequences in DNA or RNA. The irregularities such as single nucleotide polymorphism (SNP), deletions, rearrangements, and insertions lead to various diseases, including infectious diseases, cancer, viral disease, and sexually transmitted diseases (STDs). High prevalence of infectious diseases and increasing incidences of cancer are leading to high traction toward molecular diagnostics, as it is capable of diagnosing diseases with high specificity, further paving the way for treating patients with precision medicine. Various governments are focused on research and development in the field of precision medicine. Therefore, the rise in focus on molecular diagnostics is emerging as a key opportunity for the molecular biology enzymes, kits, and reagents market players.

The outbreak of the COVID-19 pandemic has come from China. The spread of infection has affected various Asian countries such as India, South Korea, Australia, Malaysia, Singapore, and others. Countries in APAC are facing challenges due to increasing incidences of COVID-19. Currently, India is the second worse hit country worldwide. Many measures have been implemented to contain the spread of COVID-19, which have resulted in significant operational disruption for many companies including in the healthcare industry. Staff quarantine, supply-chain failures, and reductions in demand have generated serious complications for companies.Rising prevalence and incidence of COVID-19 support the growth of the market in near future forecast period. Increasing launch of PCR tests for detection COVID-19 support the growth of the market. In April 2021, Fujita Health University in Toyoake has started using a fully automated coronavirus testing system from Kawasaki Heavy Industries Ltd. The machine conducts polymerase chain reaction (PCR) test to reducing the risk of infection for technicians. Therefore, the outbreak of the COVID-19 pandemic is estimated to affect high impact on molecular biology enzymes, kits & reagents industry.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC molecular biology enzymes, kits, and reagents market. The APAC molecular biology enzymes, kits, and reagents market is expected to grow at a good CAGR during the forecast period.

APAC Molecular Biology Enzymes, Kits, and Reagents Market Segmentation

 

APAC Molecular Biology Enzymes, Kits, and Reagents Market – By Product

• Enzymes
  • Polymerases
  • Ligases
  • Reverse Transcriptases
  • Phosphatases
  • Proteases and Proteinases
  • Restriction Endonuclease
  • Other
• Kits and Reagents

APAC Molecular Biology Enzymes, Kits, and Reagents Market – By Application

• Epigenetics
• Sequencing
• Synthetic Biology
• Polymerase Chain Reaction
• Other

APAC Molecular Biology Enzymes, Kits, and Reagents Market – By End User

• Biotechnological and Pharmaceutical Companies
• Hospitals and Diagnostic Centres
• Academic and Research Institutes

APAC Molecular Biology Enzymes, Kits, and Reagents Market, by Country

• Australia
• China
• India
• Japan
• South Korea
• Rest of APAC

APAC Molecular Biology Enzymes, Kits, and Reagents Market - Companies Mentioned

• F. HOFFMANN-LA ROCHE LTD
• Illumina, Inc.
• Merck KGAA
• MERIDIAN BIOSCIENCE, INC
• Promega Corporation
• Qiagen
• THERMO FISHER SCIENTIFIC INC

Asia Pacific Molecular Biology Enzymes, Kits, and Reagents Report Scope